Bautista, Remejane S.

HRN: 28-68-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
CEFUROXIME 750MG (VIAL)
03/11/2026
03/17/2026
IV
750
Q8
UTI
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive TractMultiple Infections (tick All Sites)Prophylaxis    Compliance to guidelines: Compliant To Guidelines